$100 Million

Elanco, Inc

Initial Public Offering

Passive Bookrunner, August 2018

Elanco, Inc
Elanco, an animal pharmaceutical company, develops and markets products to improve animal health and food animal production. The Company provides antibacterials, anticoccidials, vaccines, and parasiticides for pets and veterinarians in the areas of parasitology, dermatology, and surgery